Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6376
Global X S&P 500 Catholic Values ETF
CATH
$1.36B
| $1.15M | ﹤0.01% |
+24,913
| New | +$1.09M |
|
6377
CALL
Lufax Holding
LU
$1.29B
| $1.15M | ﹤0.01% |
+20,250
| New | +$1.21M |
|
6378
ALPS Sector Dividend Dogs ETF
SDOG
$1.45B
| $1.15M | ﹤0.01% |
25,757
-35,447
| -58% | -$1.49M |
|
6379
CALL
Northern Oil and Gas
NOG
$2.66B
| $1.15M | ﹤0.01% |
131,130
+117,930
| +893% | +$731K |
|
6380
ALPS REIT Dividend Dogs ETF
RDOG
$11.3M
| $1.15M | ﹤0.01% |
28,073
+12,914
| +85% | +$495K |
|
6381
PUT
Duluth Holdings
DLTH
$152M
| $1.15M | ﹤0.01% |
108,700
+85,300
| +365% | +$1.16M |
|
6382
PUT
Vontier
VNT
$4.39B
| $1.15M | ﹤0.01% |
+34,360
| New | +$1.06M |
|
6383
PUT
Seres Therapeutics
MCRB
$45.2M
| $1.15M | ﹤0.01% |
2,340
+1,710
| +271% | +$1M |
|
6384
Gibraltar Industries
ROCK
$1.4B
| $1.15M | ﹤0.01% |
15,936
+11,218
| +238% | +$749K |
|
|
FNGA
6385
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
| $1.15M | ﹤0.01% |
4,002
-1,772
| -31% | -$391K |
|
|
CLVS
6386
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.15M | ﹤0.01% |
238,900
-38,400
| -14% | -$194K |
|
6387
PUT
Alcon
ALC
$35.2B
| $1.14M | ﹤0.01% |
17,340
+1,540
| +10% | +$96.3K |
|
6388
CALL
Huazhu Hotels Group
HTHT
$14.2B
| $1.14M | ﹤0.01% |
25,400
+9,600
| +61% | +$438K |
|
6389
Rackspace Technology
RXT
$1.02B
| $1.14M | ﹤0.01% |
60,000
-60,777
| -50% | -$1.1M |
|
6390
PUT
Henry Schein
HSIC
$9.99B
| $1.14M | ﹤0.01% |
17,100
-5,300
| -24% | -$342K |
|
6391
PUT
Direxion Daily MSCI India Bull 2X ETF
INDL
$56.7M
| $1.14M | ﹤0.01% |
26,200
-26,300
| -50% | -$964K |
|
6392
Global X US Preferred ETF
PFFD
$2.16B
| $1.14M | ﹤0.01% |
+44,298
| New | +$1.12M |
|
|
PTRA
6393
DELISTED
Proterra Inc. Common Stock
PTRA
| $1.14M | ﹤0.01% |
+103,100
| New | +$1.07M |
|
|
CNR
6394
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $1.14M | ﹤0.01% |
123,117
-67,826
| -36% | -$602K |
|
6395
CALL
Rocket Pharmaceuticals
RCKT
$380M
| $1.14M | ﹤0.01% |
+20,800
| New | +$758K |
|
6396
WisdomTree US AI Enhanced Value Fund
AIVL
$436M
| $1.14M | ﹤0.01% |
+13,610
| New | +$1.09M |
|
6397
iShares MSCI Chile ETF
ECH
$1.04B
| $1.14M | ﹤0.01% |
+37,752
| New | +$1.01M |
|
6398
PUT
Progyny
PGNY
$1.94B
| $1.14M | ﹤0.01% |
26,900
-90,500
| -77% | -$2.94M |
|
6399
Victory Capital Holdings
VCTR
$7.3B
| $1.14M | ﹤0.01% |
+45,947
| New | +$940K |
|
|
HA
6400
DELISTED
Hawaiian Holdings, Inc.
HA
| $1.14M | ﹤0.01% |
64,390
-85,632
| -57% | -$1.45M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.